Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data
D. Reis Costa,
A. Winge-Main,
A. Skog,
K. Tsuruda,
T. Robsahm,
B. Andreassen
Affiliations
D. Reis Costa
The Cancer Registry of Norway, Department of Research, Oslo, Norway; Oslo University Hospital, Norwegian Research Centre for Women's Health, Oslo, Norway
A. Winge-Main
Oslo University Hospital, Department of Oncology, Oslo, Norway; University of Oslo, Faculty of Medicine, Oslo, Norway
A. Skog
The Cancer Registry of Norway, Registry Department, Oslo, Norway
K. Tsuruda
The Cancer Registry of Norway, Department of Research, Oslo, Norway
T. Robsahm
The Cancer Registry of Norway, Department of Research, Oslo, Norway
B. Andreassen
The Cancer Registry of Norway, Department of Research, Oslo, Norway
